Global Hereditary Angioedema Market Growth Fostered by Increasing Incidences of Genetic Mutations

April 24, 2023 | Healthcare

According to the latest report by IMARC Group, titled " Hereditary Angioedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2033," the global hereditary angioedema market size is witnessing steady growth. Hereditary angioedema (HAE) is a rare, autosomal dominant disorder that results in recurrent episodes of swelling that affect the face, hands, feet, and genitals. It is characterized by submucosal swelling, recurrent nonpitting, nonpruritic, and subcutaneous experiences without the appearance of urticarial lesions. It causes extreme pain, nausea, vomiting, diarrhea, fatigue, muscle ache, tingling, headache, belly pain, hoarseness, and mood changes due to blood protein deficiency. It is classified into three types, including Type I HAE, Type II HAE, and Type III HAE, depending on the formation of a dysfunctional protein. Its treatment depends on the type and severity of symptoms but may include the use of medications, such as C1 inhibitor replacement therapy, kallikrein inhibitor, and androgen therapy.

Global Hereditary Angioedema Market Trends:

The increasing incidences of hereditary angioedema (HAE) among the masses are driving the global market. This can be supported by the growing prevalence of genetic mutations leading to the disorder, elevating the demand for preventive medical care to mitigate future illness and treatment. Moreover, ongoing technological advancements in molecular biology and genetics have led to more accurate and efficient diagnostic techniques and improving patient outcomes is strengthening the overall market. Additionally, the development of novel therapies, such as gene therapies and RNA-based therapies, is acting as another growth-inducing factor. In line with this, numerous major companies are focusing on extensive research and development (R&D) activities to introduce effective drugs and novel therapies is providing a boost to the market. Furthermore, the rising initiatives and investments by the governments to improve the overall healthcare infrastructure that facilitates faster diagnosis and provide optimal treatment and care to patients are creating a positive market outlook. Apart from this, the escalating demand for personalized treatments as they aid in providing treatments to the specific needs of individual patients based on their genetic makeup and medical history is impacting the market favorably. Other factors, including rising demand for preventive care, increasing focus on patient-centric care and the increasing number of clinical trials, are also impacting the market.

Market Summary:

On the basis of the countries, the market has been classified into the United States, Germany, France, the United Kingdom, Italy, Spain, and Japan.
This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for hereditary angioedema.
The study also offers a thorough overview of the treatment practices for hereditary angioedema, the share of specific therapies, and the performance of key market players.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Hereditary Angioedema Market Growth Fostered by Increasing Incidences of Genetic Mutations

Purchase options

Single User License $6499
Five User License $9499
Corporate User License $13499

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.